These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10869578)
1. Disturbances of spatial vision and object vision correlate differently with regional cerebral glucose metabolism in Alzheimer's disease. Fujimori M; Imamura T; Hirono N; Ishii K; Sasaki M; Mori E Neuropsychologia; 2000; 38(10):1356-61. PubMed ID: 10869578 [TBL] [Abstract][Full Text] [Related]
2. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD. Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008 [TBL] [Abstract][Full Text] [Related]
3. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease. Schapiro MB; Pietrini P; Grady CL; Ball MJ; DeCarli C; Kumar A; Kaye JA; Haxby JV J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):859-64. PubMed ID: 8350100 [TBL] [Abstract][Full Text] [Related]
4. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432 [TBL] [Abstract][Full Text] [Related]
5. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography in Alzheimer's disease. Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046 [TBL] [Abstract][Full Text] [Related]
7. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment]. Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368 [TBL] [Abstract][Full Text] [Related]
10. [Change of cerebral metabolism rate of glucose of cerebral white matter in Alzheimer's disease: a study with statistical parametric mapping software]. Cao QY; Guo WH; Yang HL; Shen DW; Zhao P; Jiang KD; Zhang MY; Xiao SF Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2777-9. PubMed ID: 18167271 [TBL] [Abstract][Full Text] [Related]
11. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. Yamaguchi S; Meguro K; Itoh M; Hayasaka C; Shimada M; Yamazaki H; Yamadori A J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):596-600. PubMed ID: 9219745 [TBL] [Abstract][Full Text] [Related]
12. FDG PET imaging in patients with pathologically verified dementia. Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505 [TBL] [Abstract][Full Text] [Related]
13. Regional metabolism: associations with dyscalculia in Alzheimer's disease. Hirono N; Mori E; Ishii K; Imamura T; Shimomura T; Tanimukai S; Kazui H; Hashimoto M; Yamashita H; Sasaki M J Neurol Neurosurg Psychiatry; 1998 Dec; 65(6):913-6. PubMed ID: 9854970 [TBL] [Abstract][Full Text] [Related]
14. Cortical glucose metabolism in psychiatric wandering patients with vascular dementia. Meguro K; Yamaguchi S; Yamazaki H; Itoh M; Yamaguchi T; Matsui H; Sasaki H Psychiatry Res; 1996 May; 67(1):71-80. PubMed ID: 8797244 [TBL] [Abstract][Full Text] [Related]
15. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes. Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013 [TBL] [Abstract][Full Text] [Related]
16. Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study. Meguro K; Yamaguchi S; Itoh M; Fujiwara T; Yamadori A Neurology; 1997 Oct; 49(4):941-5. PubMed ID: 9339671 [TBL] [Abstract][Full Text] [Related]
17. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628 [TBL] [Abstract][Full Text] [Related]
18. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography. Rumsey JM; Duara R; Grady C; Rapoport JL; Margolin RA; Rapoport SI; Cutler NR Arch Gen Psychiatry; 1985 May; 42(5):448-55. PubMed ID: 3872650 [TBL] [Abstract][Full Text] [Related]
19. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition. Kessler J; Herholz K; Grond M; Heiss WD Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055 [TBL] [Abstract][Full Text] [Related]
20. The disturbances of object vision and spatial vision in Alzheimer's disease. Fujimori M; Imamura T; Yamashita H; Hirono N; Mori E Dement Geriatr Cogn Disord; 1997; 8(4):228-31. PubMed ID: 9213067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]